Evidence map›Paper›PMID 24239695›Full record

ArticleBehavioural brain research2014

Chronic nicotine attenuates phencyclidine-induced impulsivity in a mouse serial reaction time task.

Daniel Scott, Jane R Taylor

Abstract read
In one paragraph

Article in Behavioural brain research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  6. Preclinical animal anxiety research - flaws and prejudices.Pharmacology research & perspectives · 2016
    Review
  7. Review
  8. Dissociable deficits of executive function caused by gestational adversity are linked to specific transcriptional changes in the prefrontal cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Article
  9. Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.Movement disorders : official journal of the Movement Disorder Society · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel ScottDepartment of Psychiatry, Division of Molecular Psychiatry, Yale University, New Haven, CT, United States.
Jane R TaylorDepartment of Psychiatry, Division of Molecular Psychiatry, Yale University, New Haven, CT, United States. Electronic address: jane.taylor@yale.edu.

Funding

RESEARCH TRAINING - BIOLOGICAL SCIENCEST32MH014276 · NIMH · YALE UNIVERSITY · PI Marina R Picciotto · 1985 to 2026
$7.2M
COGNITIVE DYSFUNCTION AFTER CHRONIC PCP, THC AND COCAINER01DA011717 · NIDA · YALE UNIVERSITY · PI TAYLOR, JANE R · 1998 to 2014
$3.4M
NIDA NIH HHS DA011717NIDA NIH HHS R01 DA011717NIMH NIH HHS T32 MH014276PHS HHS T32-14276
6 · The paper itself

Abstract

Schizophrenia is a disorder characterized by positive, negative, and cognitive symptoms. While positive symptoms can be effectively treated with typical antipsychotic medication, which generally affects the dopaminergic system, negative and cognitive symptoms, including attentional deficits and impulsive behavior, are less sensitive to standard treatments. It has further been well documented that schizophrenic patients use tobacco products at a rate much higher than the general population, and this persists despite treatment. It has been argued this behavior may be a form of self-medication, to alleviate some symptoms of schizophrenia. It has further been posited that prefrontal glutamatergic hypofunction may underlie some aspects of schizophrenia, and in accordance with this model, systemic phencyclidine has been used to model the disease. We employed a modified 5-choice serial reaction time test, a paradigm that is often used to investigate many of the treatment-resistant symptoms of schizophrenia including impulsivity, selective attention, and sustained attention/cognitive vigilance, to determine the medicinal effects of nicotine. We demonstrate that chronic oral, but not acute injections of nicotine can selectively attenuate phencyclidine-induced increases in impulsivity without affecting other measures of attention. This suggests that nicotine use by schizophrenics may provide some relief of distinct symptoms that involve impulsive behaviors.

Indexed as

PhencyclidineAnalysis of VarianceAnimalsChoice BehaviorDrug Administration ScheduleImpulsive BehaviorLocomotionMaleMiceMice, Inbred C57BLNicotineNicotinic AgonistsPsychomotor PerformanceReaction TimeNicotineNicotinic AgonistsPhencyclidineImpulsivityNicotinePhencyclidineSchizophrenia

Identifiers

PMID24239695
PMCPMC3919629

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.